Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(7 sites)
Spain
Hospital Quironsalud Barcelona, Barcelona Hospital Universitari Dexeus Grupo Quironsalud, Barcelona Hospital Universitari Sagrat Cor, Barcelona Hospital Quironsalud Malaga, Málaga Hospital Quironsalud Malága, Málaga Hospital Universitari General De Catalunya, Sant Cugat del Vallès Hospital Quironsalud Zaragoza, Zaragoza